Novartis AG (NOVN.SW)
CHF 88.04
(-0.77%)
CHF 88.04
(-0.77%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.91 Billion USD | -17.59% |
| 2022 | 7.17 Billion USD | 7.64% |
| 2021 | 6.66 Billion USD | -6.52% |
| 2020 | 7.13 Billion USD | 19.21% |
| 2019 | 5.98 Billion USD | -14.0% |
| 2018 | 6.95 Billion USD | 1.3% |
| 2017 | 6.86 Billion USD | 9.78% |
| 2016 | 6.25 Billion USD | 0.47% |
| 2015 | 6.22 Billion USD | 2.18% |
| 2014 | 6.09 Billion USD | -16.16% |
| 2013 | 7.26 Billion USD | 7.76% |
| 2012 | 6.74 Billion USD | 13.73% |
| 2011 | 5.93 Billion USD | -2.68% |
| 2010 | 6.09 Billion USD | 4.51% |
| 2009 | 5.83 Billion USD | 0.66% |
| 2008 | 5.79 Billion USD | 6.18% |
| 2007 | 5.45 Billion USD | 21.28% |
| 2006 | 4.49 Billion USD | 20.75% |
| 2005 | 3.72 Billion USD | 4.69% |
| 2004 | 3.55 Billion USD | 6.34% |
| 2003 | 3.34 Billion USD | 12.62% |
| 2002 | 2.97 Billion USD | 19.7% |
| 2001 | 2.48 Billion USD | -1.23% |
| 2000 | 2.51 Billion USD | -41.98% |
| 1999 | 4.33 Billion USD | -10.99% |
| 1998 | 4.86 Billion USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 5.74 Billion USD | 0.07% |
| 2024 Q3 | 5.93 Billion USD | 3.34% |
| 2024 Q1 | 5.74 Billion USD | -2.88% |
| 2023 FY | 5.91 Billion USD | -17.59% |
| 2023 Q4 | 5.91 Billion USD | 5.4% |
| 2023 Q3 | 5.61 Billion USD | -31.82% |
| 2023 Q1 | 7.88 Billion USD | 9.91% |
| 2023 Q2 | 8.22 Billion USD | 4.34% |
| 2022 Q3 | 6.77 Billion USD | -1.47% |
| 2022 Q4 | 7.17 Billion USD | 5.84% |
| 2022 FY | 7.17 Billion USD | 7.64% |
| 2022 Q1 | 6.99 Billion USD | 4.97% |
| 2022 Q2 | 6.88 Billion USD | -1.67% |
| 2021 Q1 | 6.99 Billion USD | -1.88% |
| 2021 Q2 | 7.11 Billion USD | 1.63% |
| 2021 FY | 6.66 Billion USD | -6.52% |
| 2021 Q3 | 6.88 Billion USD | -3.18% |
| 2021 Q4 | 6.66 Billion USD | -3.18% |
| 2020 Q2 | 6.9 Billion USD | 7.91% |
| 2020 Q3 | 7.13 Billion USD | 3.36% |
| 2020 Q4 | 7.13 Billion USD | -0.07% |
| 2020 Q1 | 6.39 Billion USD | 6.95% |
| 2020 FY | 7.13 Billion USD | 19.21% |
| 2019 Q4 | 5.98 Billion USD | -2.3% |
| 2019 Q1 | 5.72 Billion USD | -17.65% |
| 2019 FY | 5.98 Billion USD | -14.0% |
| 2019 Q2 | 6.09 Billion USD | 6.39% |
| 2019 Q3 | 6.12 Billion USD | 0.48% |
| 2018 Q1 | 7.22 Billion USD | 5.24% |
| 2018 Q4 | 6.95 Billion USD | 0.06% |
| 2018 FY | 6.95 Billion USD | 1.3% |
| 2018 Q3 | 6.95 Billion USD | -2.04% |
| 2018 Q2 | 7.09 Billion USD | -1.8% |
| 2017 Q3 | 6.95 Billion USD | 0.77% |
| 2017 Q2 | 6.9 Billion USD | 4.83% |
| 2017 Q1 | 6.58 Billion USD | 5.24% |
| 2017 Q4 | 6.86 Billion USD | -1.25% |
| 2017 FY | 6.86 Billion USD | 9.78% |
| 2016 FY | 6.25 Billion USD | 0.47% |
| 2016 Q3 | 6.77 Billion USD | 1.48% |
| 2016 Q2 | 6.67 Billion USD | 0.66% |
| 2016 Q1 | 6.63 Billion USD | 6.49% |
| 2016 Q4 | 6.25 Billion USD | -7.65% |
| 2015 Q2 | 6.61 Billion USD | 5.47% |
| 2015 FY | 6.22 Billion USD | 2.18% |
| 2015 Q1 | 6.27 Billion USD | 2.92% |
| 2015 Q3 | 6.56 Billion USD | -0.79% |
| 2015 Q4 | 6.22 Billion USD | -5.12% |
| 2014 Q1 | 7.86 Billion USD | 8.16% |
| 2014 FY | 6.09 Billion USD | -16.16% |
| 2014 Q4 | 6.09 Billion USD | -6.43% |
| 2014 Q2 | 6.88 Billion USD | -12.47% |
| 2014 Q3 | 6.51 Billion USD | -5.35% |
| 2013 Q1 | 7.02 Billion USD | 4.11% |
| 2013 FY | 7.26 Billion USD | 7.76% |
| 2013 Q4 | 7.26 Billion USD | -3.31% |
| 2013 Q3 | 7.51 Billion USD | 3.48% |
| 2013 Q2 | 7.26 Billion USD | 3.45% |
| 2012 Q4 | 6.74 Billion USD | -1.48% |
| 2012 Q1 | 6.45 Billion USD | 8.9% |
| 2012 Q2 | 6.42 Billion USD | -0.59% |
| 2012 Q3 | 6.84 Billion USD | 6.62% |
| 2012 FY | 6.74 Billion USD | 13.73% |
| 2011 Q1 | 6.62 Billion USD | 8.67% |
| 2011 FY | 5.93 Billion USD | -2.68% |
| 2011 Q4 | 5.93 Billion USD | -10.22% |
| 2011 Q3 | 6.6 Billion USD | -6.91% |
| 2011 Q2 | 7.09 Billion USD | 7.16% |
| 2010 FY | 6.09 Billion USD | 4.51% |
| 2010 Q3 | 6.75 Billion USD | 21.95% |
| 2010 Q4 | 6.09 Billion USD | -9.81% |
| 2010 Q1 | 5.65 Billion USD | -2.95% |
| 2010 Q2 | 5.54 Billion USD | -2.09% |
| 2009 Q4 | 5.83 Billion USD | -7.58% |
| 2009 FY | 5.83 Billion USD | 0.66% |
| 2009 Q1 | 5.76 Billion USD | -0.48% |
| 2009 Q2 | 6.13 Billion USD | 6.35% |
| 2009 Q3 | 6.3 Billion USD | 2.9% |
| 2008 Q1 | 6.24 Billion USD | 14.41% |
| 2008 Q4 | 5.79 Billion USD | -2.79% |
| 2008 FY | 5.79 Billion USD | 6.18% |
| 2008 Q2 | 6.45 Billion USD | 3.35% |
| 2008 Q3 | 5.95 Billion USD | -7.63% |
| 2007 Q2 | 5.02 Billion USD | 0.8% |
| 2007 FY | 5.45 Billion USD | 21.28% |
| 2007 Q1 | 4.98 Billion USD | 10.76% |
| 2007 Q4 | 5.45 Billion USD | 3.55% |
| 2007 Q3 | 5.26 Billion USD | 4.9% |
| 2006 Q3 | 4.61 Billion USD | -1.71% |
| 2006 FY | 4.49 Billion USD | 20.75% |
| 2006 Q1 | 3.92 Billion USD | 5.4% |
| 2006 Q4 | 4.49 Billion USD | -2.43% |
| 2006 Q2 | 4.69 Billion USD | 19.46% |
| 2005 FY | 3.72 Billion USD | 4.69% |
| 2005 Q4 | 3.72 Billion USD | -4.22% |
| 2005 Q2 | 3.96 Billion USD | 14.35% |
| 2005 Q1 | 3.47 Billion USD | -2.47% |
| 2005 Q3 | 3.88 Billion USD | -1.99% |
| 2004 FY | 3.55 Billion USD | 6.34% |
| 2004 Q4 | 3.55 Billion USD | 3.43% |
| 2004 Q3 | 3.44 Billion USD | -0.52% |
| 2004 Q2 | 3.45 Billion USD | 0.99% |
| 2004 Q1 | 3.42 Billion USD | 2.33% |
| 2003 Q4 | 3.34 Billion USD | 3.56% |
| 2003 FY | 3.34 Billion USD | 12.62% |
| 2003 Q2 | 3.26 Billion USD | 3.88% |
| 2003 Q1 | 3.14 Billion USD | 5.92% |
| 2003 Q3 | 3.23 Billion USD | -1.16% |
| 2002 Q2 | 2.78 Billion USD | 0.0% |
| 2002 Q4 | 2.97 Billion USD | 6.34% |
| 2002 Q3 | 2.79 Billion USD | 0.32% |
| 2002 FY | 2.97 Billion USD | 19.7% |
| 2001 Q2 | 2.48 Billion USD | 0.0% |
| 2001 FY | 2.48 Billion USD | -1.23% |
| 2001 Q4 | 2.48 Billion USD | 0.0% |
| 2000 Q4 | 2.51 Billion USD | 0.0% |
| 2000 Q2 | 3.94 Billion USD | 0.0% |
| 2000 FY | 2.51 Billion USD | -41.98% |
| 1999 FY | 4.33 Billion USD | -10.99% |
| 1998 FY | 4.86 Billion USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Roche Holding AG | 7.74 Billion CHF | 23.693% |
| Roche Holding AG | 7.74 Billion CHF | 23.693% |